1.46

2.67% -0.04

Biorestorative Therapies Inc (BRTX)

Overview News Price History Financials Discussions Forecast Stock Split

Biorestorative Therapies Inc stock is traded at $1.46, with a volume of 27,800. It is down -2.67% in the last 24 hours and down -44.70% over the past month. BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Previous Close:

$1.50

Open:

$1.5

24h Volume:

27,800

Relative Volume:

0.64

Market Cap:

$2.02M

Revenue:

$357.90K

Net Income/Loss:

$-11.06M

P/E Ratio:

-1.3035

EPS:

-1.1201

Net Cash Flow:

$-11.90M

1W Performance:

-22.75%

1M Performance:

-44.70%

6M Performance:

-71.92%

1Y Performance:

-95.44%

1-Day Range:

$1.28

$1.50

1-Week Range:

$1.28

$1.95

52-Week Range:

$1.28

$34.40

Biorestorative Therapies Inc Stock (BRTX) Company Profile

Name

Biorestorative Therapies Inc

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

(631) 760-8100

Address

40 MARCUS DRIVE, MELVILLE

Employee

Twitter

Next Earnings Date

2026-11-11

Latest SEC Filings

BRTX's Discussions on Twitter

Compare BRTX vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BRTX Biorestorative Therapies Inc	1.46	2.02M	357.90K	-11.06M	-11.90M	-1.1201
VRTX Vertex Pharmaceuticals Inc	508.75	128.95B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	236.50	94.42B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	796.34	81.99B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.27	53.22B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	374.08	42.32B	5.76B	514.49M	1.10B	4.4813

Biorestorative Therapies Inc Stock (BRTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-06-26	Downgrade	Maxim Group	Buy → Hold

Biorestorative Therapies Inc Stock (BRTX) Latest News

Sep 11, 2026

BioRestorative Therapies reports resignation of vice president of R&D By Investing.com - Investing.com South Africa

Sep 11, 2026

BioRestorative Therapies reports resignation of vice president of R&D - Investing.com

Sep 11, 2026

Form 8K BioRestorative Therapies Inc For: 11 September By Investing.com - Investing.com India

Sep 11, 2026

BioRestorative Therapies reports resignation of vice president of R&D By Investing.com - Investing.com UK

Sep 11, 2026

BioRestorative Therapies reports resignation of vice president of R&D - Investing.com

Sep 11, 2026

Form 8K BioRestorative Therapies Inc For: 11 September By Investing.com - Investing.com Canada

Sep 11, 2026

Form 8K BioRestorative Therapies Inc For: 11 September By Investing.com - Investing.com UK

Sep 11, 2026

BioRestorative Therapies Faces Disputed Executive Resignation Claim - TipRanks

Sep 11, 2026

BioRestorative Therapies Inc expected to post a loss of $2.50 a shareEarnings Preview - TradingView

Sep 11, 2026

Sep 10, 2026

BioRestorative Therapies, Inc. Revenue Breakdown – MUN:9OF0 - TradingView

Sep 10, 2026

Sep 09, 2026

BioRestorative Therapies, Inc. Earnings and Revenue – FWB:9OF0 - TradingView

Sep 09, 2026

Sep 04, 2026

BioRestorative Therapies Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView

Sep 04, 2026

Sep 03, 2026

Biorestorative Therapies To Carry Out 1-for-20 Reverse Stock Split On September 8th, 2026 - Moomoo

Sep 03, 2026